共 288 条
[1]
Bigelow E(2013)Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue J Vis Exp 71 4059-32
[2]
Bever KM(2014)Immunological off-target effects of standard treatments in gastrointestinal cancers Ann Oncol 25 24-247
[3]
Xu H(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228-233
[4]
Yager A(2012)The secret ally: immunostimulation by anticancer drugs Nat Rev Drug Discov 11 215-88
[5]
Wu A(2016)Immune checkpoint inhibitors in non-small cell lung cancer Oncologist 22 81-1508
[6]
Taube J(2013)Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas PLoS One 8 e82870-2520
[7]
Chen L(2016)Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study Lancet Oncol 17 1497-720
[8]
Jaffee EM(2015)PD-1 blockade in tumors with mismatch-repair deficiency N Engl J Med 372 2509-3943
[9]
Anders RA(2009)Dose escalation methods in phase I cancer clinical trials J Natl Cancer Inst 101 708-2979
[10]
Zheng L(2013)Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements Clin Cancer Res 19 3936-1117